← Back to Clinical Trials
Recruiting NCT06909734

NCT06909734 Trauma-Informed Motivational Interviewing in Rural Dwelling Samples

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06909734
Status Recruiting
Phase
Sponsor Alexandria University
Condition Discrimination, Perceived
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2025-03-01
Primary Completion 2025-09-20

Eligibility & Interventions

Sex All sexes
Min Age 25 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Trauma-Informed Motivational Interviewing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2025-03-01 with a primary completion date of 2025-09-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Leprosy remains a profoundly stigmatized condition in many rural communities worldwide, fostering social exclusion, body image dissatisfaction, and diminished mental health outcomes. TTrauma-Informed Motivational Interviewing (TIMI) emerges as a promising paradigm to address these psychosocial challenges, enhancing resilience, improving self-perception, and fostering social re-engagement.

Eligibility Criteria

Inclusion Criteria: * Individuals with a confirmed medical diagnosis of leprosy (current or past) experiencing physical, emotional, or social consequences. Exclusion Criteria: * Severe Cognitive or Psychiatric Impairments: Individuals with severe mental health conditions (e.g., untreated psychosis, severe intellectual disabilities) that impede the reflective, goal-setting nature of Motivational Interviewing.

Contact & Investigator

Central Contact

rasha eweida

✉ rashapsych@alexu.edu.eg

📞 +201286640701

Principal Investigator

rasha eweida

PRINCIPAL INVESTIGATOR

Alexandria University

Frequently Asked Questions

Who can join the NCT06909734 clinical trial?

This trial is open to participants of all sexes, aged 25 Years or older, up to 65 Years, studying Discrimination, Perceived. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06909734 currently recruiting?

Yes, NCT06909734 is actively recruiting participants. Contact the research team at rashapsych@alexu.edu.eg for enrollment information.

Where is the NCT06909734 trial being conducted?

This trial is being conducted at Alexandria, Egypt.

Who is sponsoring the NCT06909734 clinical trial?

NCT06909734 is sponsored by Alexandria University. The principal investigator is rasha eweida at Alexandria University. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology